I really don't want to be a doctor

Chapter 340 New Research and Development Results
In the next few days, Jing Xiaoran did his own experiments with peace of mind.

The combination of this laboratory is a bit strange, one Chinese and two Japanese, the two ethnic groups once had a blood feud, but fortunately there was no conflict.

Jing Xiaoran also didn't bother to pay attention to the fat and thin Toutuo on the other side of the laboratory, trying to push forward the progress of his "replacing protein" experiment.

Huaxia, Fancheng, Shenzhou Laboratory.

Zhu Xianqing is concentrating on the experimental reactor in front of him. This is the last few steps in the synthesis of "immune checkpoint inhibitors", and it is also an important step.

"call……"

At the end of the experiment, Zhu Xianqing let out a long breath, but it still failed.

He has been repeating this step of the experiment for nearly a month, but it has never been successful.

After rubbing his temples, he prepared relevant reagents again, and Zhu Xianqing prepared to conduct another experiment.

At present, the international competition for the development of drugs such as "immune checkpoint inhibitors" is at a fever pitch.

"Immune checkpoint inhibitors" have gone from being tepid in the past two years to a completely popular trend this year. More and more basic laboratories have proved the effectiveness of such drugs against tumors.

Almost all research and development funds in the field of oncology medicine are invested in it.

Several major pharmaceutical companies in the United States, such as AstraZeneca and Pfizer, have published important experimental papers, and Europe and Japan are not far behind. They have invested heavily in the research of "immune checkpoint inhibitors" and want to further speed up the experimental process .

On the other hand, in China, apart from Shenzhou Laboratory and a large Li's pharmaceutical factory, other laboratories or pharmaceutical companies are not eligible to enter this scientific research competition, and Li's large pharmaceutical factory is only a role of accompanying runners. They have just entered this scientific research competition. field soon.

From this point of view, it is enough to see that China's scientific research level is really very backward.

"Failed again!"

Zhu Xianqing was a little annoyed and poured all the reagents into the pool, leaving the experimental data record book aside.

This kind of scene is rarely seen on him.

From being smug at the beginning to being depressed now, Zhu Xianqing also clearly realizes that he has entered the bottleneck period of research.

He hadn't experienced this feeling for a long time since he came to Shenzhou Laboratory.

Whenever encountering scientific research problems, Jing Xiaoran would stand up and solve them in time, and even if he couldn't solve them completely, he could still give good suggestions.

But now, Jing Xiaoran has gone to Africa, and none of the Shenzhou laboratories can solve the problem of "immune checkpoint inhibitors".

"What should we do?" Zhu Xianqing flipped through the literature in his hand, "According to the current research and development speed abroad, AstraZeneca is ahead of all laboratories and pharmaceutical companies. If our Shenzhou laboratory does not seek breakthroughs, this first A scientific research competition is about to be lost!"

For scientific research competitions, only No.1 is recognized, No.2 is not.

As long as No.1 appears and the relevant drug patents are applied for, all other labs' investment will be in vain!
Unless we can find another drug synthesis method, but how difficult it is!
Medical research is a money-burning industry, and the basic unit is "[-] million"!
Shenzhou Laboratories has also invested a lot of money in the development of "immune checkpoint inhibitors".

Jing Xiaoran transferred the patent fees of the "New Oral Anticoagulant Drug" he transferred, and more than half of it was invested in the research and development of medicine.

If this scientific research competition fails, it will really be a heavy loss. It is unlikely that the Shenzhou Laboratory will recover in the past five years.

"Boom! Boom!"

A knock on the door came from outside the laboratory, interrupting Zhu Xianqing's troubled thoughts.

"Come in!"

Zhu Xianqing shouted at the door, and at the same time tidied up the experimental reagents on the table.

Lin Yitian walked into the laboratory with a smile and said loudly: "Old Zhu, good news!"

"What good news? Xiao Ran has returned to China?" Zhu Xianqing looked at Lin Yitian suspiciously. For him, this may be considered good news at present.

"Hey, no, I really want Xiao Ran to go back to China." Lin Yitian shook his head and smiled, "But it's only been a month. He seems to be staying in Africa for at least three months, right?"

"Then what good news can there be?" Zhu Xianqing sighed.

Lin Yitian rubbed his palms, with a smile on his face, and said excitedly, "Our laboratory has a new research and development result!"

"New research and development results?" Zhu Xianqing looked at Lin Yitian in surprise, "I don't have anything here!"

Lin Yitian explained with a smile: "Old Zhu, have you forgotten the R&D project on myocardial mesenchymal stem cells?"

"Of course I remember." Zhu Xianqing nodded and said, "But didn't Jeffrey also go to Africa?"

At present, there are only two research projects in the entire Shenzhou Biopharmaceutical Laboratory.

The first one is "Immune Checkpoint Inhibitors", chaired by Zhu Xianqing.

The other is "Myocardial Mesenchymal Stem Cells", hosted by Jeffrey.

Now that his research and development process has been blocked, and Jeffrey has also followed Jing Xiaoran to Africa, what new research and development results can there be?
"Although Jeffrey is gone, their team members are still there!" Yitian Lin said with a smile.

"Myocardial mesenchymal stem cell team?" Zhu Xianqing asked tentatively, "I remember that in Jeffrey's team, the most important member is Hong Sheng, right? There are no other people!"

The main experimental project of Shenzhou Laboratory is "Immune Checkpoint Inhibitor". The "Myocardial Mesenchymal Stem Cell" project is just incidental. Jing Xiaoran doesn't pay much attention to it, just let it develop on its own.

"Yes, that kid Hong Sheng!" Lin Yitian nodded, "Because Jeffrey encountered a problem in the experiment and couldn't solve it for a while, so he went to Africa for a visit. Unexpectedly, this difficulty was solved by Hong Sheng Already!"

Zhu Xianqing was a little surprised. This Hong Sheng seemed to be Jing Xiaoran's roommate, and he was only in his junior year, right?
Why are junior students so good?
It's fine if there is one Jing Xiaoran, why is there another one now?
You know, Jeffrey is a doctor of the National Laboratory of the United States. This is not a "pheasant" laboratory, but one of the top laboratories in the United States!

A problem that even he couldn't solve, was actually solved by this little kid like Hong Sheng?

"Where are Hong Sheng and others?" Zhu Xianqing asked aloud.

"It's in the laboratory on the first floor. Many people are there now." Lin Yitian replied.

"Okay, let's go and see!"

On the first floor, the laboratory of "Myocardial Mesenchymal Stem Cells" is full of people.

Hong Sheng stood among the crowd, explaining something to everyone.

"Teacher Zhu is here."

Who knows who yelled, and everyone dispersed one after another, making way for Zhu Xianqing.

(End of this chapter)